APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biliary Tract Disorder Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biliary Tract Disorder Treatment Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchBiliary Tract Disorder Treatment Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Biliary Tract Disorder Treatment Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Biliary Tract Disorder Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biliary Tract Disorder Treatment Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Biliary Tract Disorder Treatment Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Biliary Tract Disorder Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biliary Tract Disorder Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biliary Tract Disorder Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biliary Tract Disorder Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biliary Tract Disorder Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biliary Tract Disorder Treatment market include Abbott Laboratories, Asklepion Pharmaceuticals, B. Braun Melsungen, Becton Dickinson, Boston Scientific, Conmed, Cook Medical, Intuitive Surgical and Merit Medical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Biliary Tract Disorder Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biliary Tract Disorder Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biliary Tract Disorder Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biliary Tract Disorder Treatment market.

Biliary Tract Disorder Treatment Segment by Company

Abbott Laboratories

Asklepion Pharmaceuticals

B. Braun Melsungen

Becton Dickinson

Boston Scientific

Conmed

Cook Medical

Intuitive Surgical

Merit Medical

Olympus

Terumo

AstraZeneca

Medtronic

Merck

Biliary Tract Disorder Treatment Segment by Type

Mecine

Surgery

Other

Biliary Tract Disorder Treatment Segment by Application

Hospitals

Clinics

Other

Biliary Tract Disorder Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biliary Tract Disorder Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biliary Tract Disorder Treatment key companies, revenue, market share, and recent developments.

3. To split the Biliary Tract Disorder Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biliary Tract Disorder Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biliary Tract Disorder Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Biliary Tract Disorder Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biliary Tract Disorder Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biliary Tract Disorder Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biliary Tract Disorder Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biliary Tract Disorder Treatment industry.

Chapter 3: Detailed analysis of Biliary Tract Disorder Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biliary Tract Disorder Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biliary Tract Disorder Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biliary Tract Disorder Treatment Industry Trends Table 2. Biliary Tract Disorder Treatment Industry Drivers Table 3. Biliary Tract Disorder Treatment Industry Opportunities and Challenges Table 4. Biliary Tract Disorder Treatment Industry Restraints Table 5. Global Biliary Tract Disorder Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biliary Tract Disorder Treatment Revenue Share by Company (2021-2026) Table 7. Global Biliary Tract Disorder Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biliary Tract Disorder Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Biliary Tract Disorder Treatment Company, Product Type & Application Table 10. Global Biliary Tract Disorder Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biliary Tract Disorder Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Mecine Table 15. Significant Companies of Surgery Table 16. Significant Companies of Other Table 17. Global Biliary Tract Disorder Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Biliary Tract Disorder Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Biliary Tract Disorder Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Biliary Tract Disorder Treatment Sales Value Share by Type (2021-2026) Table 21. Global Biliary Tract Disorder Treatment Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Clinics Table 24. Significant Companies of Other Table 25. Global Biliary Tract Disorder Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Biliary Tract Disorder Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Biliary Tract Disorder Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Biliary Tract Disorder Treatment Sales Value Share by Application (2021-2026) Table 29. Global Biliary Tract Disorder Treatment Sales Value Share by Application (2027-2032) Table 30. Global Biliary Tract Disorder Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Biliary Tract Disorder Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Biliary Tract Disorder Treatment Sales Value Share by Region (2021-2026) Table 33. Global Biliary Tract Disorder Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Biliary Tract Disorder Treatment Sales Value Share by Region (2027-2032) Table 35. Global Biliary Tract Disorder Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Biliary Tract Disorder Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Biliary Tract Disorder Treatment Sales Value Market Share by Country (2021-2026) Table 38. Global Biliary Tract Disorder Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Biliary Tract Disorder Treatment Sales Value Market Share by Country (2027-2032) Table 40. Abbott Laboratories Company Information Table 41. Abbott Laboratories Business Overview Table 42. Abbott Laboratories Biliary Tract Disorder Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Abbott Laboratories Biliary Tract Disorder Treatment Product Portfolio Table 44. Abbott Laboratories Recent Development Table 45. Asklepion Pharmaceuticals Company Information Table 46. Asklepion Pharmaceuticals Business Overview Table 47. Asklepion Pharmaceuticals Biliary Tract Disorder Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Asklepion Pharmaceuticals Biliary Tract Disorder Treatment Product Portfolio Table 49. Asklepion Pharmaceuticals Recent Development Table 50. B. Braun Melsungen Company Information Table 51. B. Braun Melsungen Business Overview Table 52. B. Braun Melsungen Biliary Tract Disorder Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. B. Braun Melsungen Biliary Tract Disorder Treatment Product Portfolio Table 54. B. Braun Melsungen Recent Development Table 55. Becton Dickinson Company Information Table 56. Becton Dickinson Business Overview Table 57. Becton Dickinson Biliary Tract Disorder Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Becton Dickinson Biliary Tract Disorder Treatment Product Portfolio Table 59. Becton Dickinson Recent Development Table 60. Boston Scientific Company Information Table 61. Boston Scientific Business Overview Table 62. Boston Scientific Biliary Tract Disorder Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Boston Scientific Biliary Tract Disorder Treatment Product Portfolio Table 64. Boston Scientific Recent Development Table 65. Conmed Company Information Table 66. Conmed Business Overview Table 67. Conmed Biliary Tract Disorder Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Conmed Biliary Tract Disorder Treatment Product Portfolio Table 69. Conmed Recent Development Table 70. Cook Medical Company Information Table 71. Cook Medical Business Overview Table 72. Cook Medical Biliary Tract Disorder Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Cook Medical Biliary Tract Disorder Treatment Product Portfolio Table 74. Cook Medical Recent Development Table 75. Intuitive Surgical Company Information Table 76. Intuitive Surgical Business Overview Table 77. Intuitive Surgical Biliary Tract Disorder Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Intuitive Surgical Biliary Tract Disorder Treatment Product Portfolio Table 79. Intuitive Surgical Recent Development Table 80. Merit Medical Company Information Table 81. Merit Medical Business Overview Table 82. Merit Medical Biliary Tract Disorder Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Merit Medical Biliary Tract Disorder Treatment Product Portfolio Table 84. Merit Medical Recent Development Table 85. Olympus Company Information Table 86. Olympus Business Overview Table 87. Olympus Biliary Tract Disorder Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Olympus Biliary Tract Disorder Treatment Product Portfolio Table 89. Olympus Recent Development Table 90. Terumo Company Information Table 91. Terumo Business Overview Table 92. Terumo Biliary Tract Disorder Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Terumo Biliary Tract Disorder Treatment Product Portfolio Table 94. Terumo Recent Development Table 95. AstraZeneca Company Information Table 96. AstraZeneca Business Overview Table 97. AstraZeneca Biliary Tract Disorder Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. AstraZeneca Biliary Tract Disorder Treatment Product Portfolio Table 99. AstraZeneca Recent Development Table 100. Medtronic Company Information Table 101. Medtronic Business Overview Table 102. Medtronic Biliary Tract Disorder Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Medtronic Biliary Tract Disorder Treatment Product Portfolio Table 104. Medtronic Recent Development Table 105. Merck Company Information Table 106. Merck Business Overview Table 107. Merck Biliary Tract Disorder Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Merck Biliary Tract Disorder Treatment Product Portfolio Table 109. Merck Recent Development Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Biliary Tract Disorder Treatment Product Image Figure 2. Global Biliary Tract Disorder Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biliary Tract Disorder Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Biliary Tract Disorder Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Mecine Image Figure 8. Surgery Image Figure 9. Other Image Figure 10. Global Biliary Tract Disorder Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Biliary Tract Disorder Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Biliary Tract Disorder Treatment Sales Value Share by Type (2021-2032) Figure 13. Hospitals Image Figure 14. Clinics Image Figure 15. Other Image Figure 16. Global Biliary Tract Disorder Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Biliary Tract Disorder Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Biliary Tract Disorder Treatment Sales Value Share by Application (2021-2032) Figure 19. Global Biliary Tract Disorder Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Biliary Tract Disorder Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Biliary Tract Disorder Treatment Sales Value (2021-2032) & (US$ Million) Figure 22. North America Biliary Tract Disorder Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Biliary Tract Disorder Treatment Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Biliary Tract Disorder Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Biliary Tract Disorder Treatment Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Biliary Tract Disorder Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Biliary Tract Disorder Treatment Sales Value (2021-2032) & (US$ Million) Figure 28. South America Biliary Tract Disorder Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Biliary Tract Disorder Treatment Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Biliary Tract Disorder Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Mecine
  • Surgery
  • Other
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Abbott Laboratories
  • Asklepion Pharmaceuticals
  • B. Braun Melsungen
  • Becton Dickinson
  • Boston Scientific
  • Conmed
  • Cook Medical
  • Intuitive Surgical
  • Merit Medical
  • Olympus
  • Terumo
  • AstraZeneca
  • Medtronic
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biliary Tract Disorder Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biliary Tract Disorder Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biliary Tract Disorder Treatment Market Dynamics
  1. 2.1 Biliary Tract Disorder Treatment Industry Trends
  2. 2.2 Biliary Tract Disorder Treatment Industry Drivers
  3. 2.3 Biliary Tract Disorder Treatment Industry Opportunities and Challenges
  4. 2.4 Biliary Tract Disorder Treatment Industry Restraints
3 Biliary Tract Disorder Treatment Market by Company
  1. 3.1 Global Biliary Tract Disorder Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Biliary Tract Disorder Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Biliary Tract Disorder Treatment Company Ranking (2024-2026)
  4. 3.4 Global Biliary Tract Disorder Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Biliary Tract Disorder Treatment Company Product Type and Application
  6. 3.6 Global Biliary Tract Disorder Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biliary Tract Disorder Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biliary Tract Disorder Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biliary Tract Disorder Treatment Market by Type
  1. 4.1 Biliary Tract Disorder Treatment Type Introduction
  2. 4.1.1 Mecine
  3. 4.1.2 Surgery
  4. 4.1.3 Other
  5. 4.2 Global Biliary Tract Disorder Treatment Sales Value by Type
  6. 4.2.1 Global Biliary Tract Disorder Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Biliary Tract Disorder Treatment Sales Value by Type (2021-2032)
  8. 4.2.3 Global Biliary Tract Disorder Treatment Sales Value Share by Type (2021-2032)
5 Biliary Tract Disorder Treatment Market by Application
  1. 5.1 Biliary Tract Disorder Treatment Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Biliary Tract Disorder Treatment Sales Value by Application
  6. 5.2.1 Global Biliary Tract Disorder Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biliary Tract Disorder Treatment Sales Value by Application (2021-2032)
  8. 5.2.3 Global Biliary Tract Disorder Treatment Sales Value Share by Application (2021-2032)
6 Biliary Tract Disorder Treatment Regional Value Analysis
  1. 6.1 Global Biliary Tract Disorder Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biliary Tract Disorder Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biliary Tract Disorder Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biliary Tract Disorder Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biliary Tract Disorder Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Biliary Tract Disorder Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biliary Tract Disorder Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Biliary Tract Disorder Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biliary Tract Disorder Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biliary Tract Disorder Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biliary Tract Disorder Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Biliary Tract Disorder Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biliary Tract Disorder Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biliary Tract Disorder Treatment Sales Value Share by Country, 2025 VS 2032
7 Biliary Tract Disorder Treatment Country-level Value Analysis
  1. 7.1 Global Biliary Tract Disorder Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biliary Tract Disorder Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biliary Tract Disorder Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biliary Tract Disorder Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biliary Tract Disorder Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biliary Tract Disorder Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biliary Tract Disorder Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Biliary Tract Disorder Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Biliary Tract Disorder Treatment Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Asklepion Pharmaceuticals
  8. 8.2.1 Asklepion Pharmaceuticals Company Information
  9. 8.2.2 Asklepion Pharmaceuticals Business Overview
  10. 8.2.3 Asklepion Pharmaceuticals Biliary Tract Disorder Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Asklepion Pharmaceuticals Biliary Tract Disorder Treatment Product Portfolio
  12. 8.2.5 Asklepion Pharmaceuticals Recent Developments
  13. 8.3 B. Braun Melsungen
  14. 8.3.1 B. Braun Melsungen Company Information
  15. 8.3.2 B. Braun Melsungen Business Overview
  16. 8.3.3 B. Braun Melsungen Biliary Tract Disorder Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 B. Braun Melsungen Biliary Tract Disorder Treatment Product Portfolio
  18. 8.3.5 B. Braun Melsungen Recent Developments
  19. 8.4 Becton Dickinson
  20. 8.4.1 Becton Dickinson Company Information
  21. 8.4.2 Becton Dickinson Business Overview
  22. 8.4.3 Becton Dickinson Biliary Tract Disorder Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Becton Dickinson Biliary Tract Disorder Treatment Product Portfolio
  24. 8.4.5 Becton Dickinson Recent Developments
  25. 8.5 Boston Scientific
  26. 8.5.1 Boston Scientific Company Information
  27. 8.5.2 Boston Scientific Business Overview
  28. 8.5.3 Boston Scientific Biliary Tract Disorder Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Boston Scientific Biliary Tract Disorder Treatment Product Portfolio
  30. 8.5.5 Boston Scientific Recent Developments
  31. 8.6 Conmed
  32. 8.6.1 Conmed Company Information
  33. 8.6.2 Conmed Business Overview
  34. 8.6.3 Conmed Biliary Tract Disorder Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Conmed Biliary Tract Disorder Treatment Product Portfolio
  36. 8.6.5 Conmed Recent Developments
  37. 8.7 Cook Medical
  38. 8.7.1 Cook Medical Company Information
  39. 8.7.2 Cook Medical Business Overview
  40. 8.7.3 Cook Medical Biliary Tract Disorder Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cook Medical Biliary Tract Disorder Treatment Product Portfolio
  42. 8.7.5 Cook Medical Recent Developments
  43. 8.8 Intuitive Surgical
  44. 8.8.1 Intuitive Surgical Company Information
  45. 8.8.2 Intuitive Surgical Business Overview
  46. 8.8.3 Intuitive Surgical Biliary Tract Disorder Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Intuitive Surgical Biliary Tract Disorder Treatment Product Portfolio
  48. 8.8.5 Intuitive Surgical Recent Developments
  49. 8.9 Merit Medical
  50. 8.9.1 Merit Medical Company Information
  51. 8.9.2 Merit Medical Business Overview
  52. 8.9.3 Merit Medical Biliary Tract Disorder Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merit Medical Biliary Tract Disorder Treatment Product Portfolio
  54. 8.9.5 Merit Medical Recent Developments
  55. 8.10 Olympus
  56. 8.10.1 Olympus Company Information
  57. 8.10.2 Olympus Business Overview
  58. 8.10.3 Olympus Biliary Tract Disorder Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Olympus Biliary Tract Disorder Treatment Product Portfolio
  60. 8.10.5 Olympus Recent Developments
  61. 8.11 Terumo
  62. 8.11.1 Terumo Company Information
  63. 8.11.2 Terumo Business Overview
  64. 8.11.3 Terumo Biliary Tract Disorder Treatment Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Terumo Biliary Tract Disorder Treatment Product Portfolio
  66. 8.11.5 Terumo Recent Developments
  67. 8.12 AstraZeneca
  68. 8.12.1 AstraZeneca Company Information
  69. 8.12.2 AstraZeneca Business Overview
  70. 8.12.3 AstraZeneca Biliary Tract Disorder Treatment Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AstraZeneca Biliary Tract Disorder Treatment Product Portfolio
  72. 8.12.5 AstraZeneca Recent Developments
  73. 8.13 Medtronic
  74. 8.13.1 Medtronic Company Information
  75. 8.13.2 Medtronic Business Overview
  76. 8.13.3 Medtronic Biliary Tract Disorder Treatment Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Medtronic Biliary Tract Disorder Treatment Product Portfolio
  78. 8.13.5 Medtronic Recent Developments
  79. 8.14 Merck
  80. 8.14.1 Merck Company Information
  81. 8.14.2 Merck Business Overview
  82. 8.14.3 Merck Biliary Tract Disorder Treatment Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Merck Biliary Tract Disorder Treatment Product Portfolio
  84. 8.14.5 Merck Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst